Nucala (mepolizumab) has a half-life of about 3 to 4 weeks, meaning it takes roughly 4 to 5 months for a single dose to fully clear your system. Because the drug is given every 4 weeks and builds up over time, the total clearance window after your last injection can stretch a bit longer. But the more practical question for most people is how long its effects last after stopping, and that timeline follows a different clock than the drug itself.
Half-Life and Full Elimination
Nucala’s elimination half-life in people with asthma is 3 to 4 weeks. In healthy subjects without asthma, the range is slightly wider: 20 to 36 days. A half-life is the time it takes for half of the drug to leave your bloodstream. After one half-life, 50% remains. After two, 25%. After three, 12.5%. Most medications are considered effectively cleared after about 5 half-lives.
For Nucala, that math works out to roughly 15 to 20 weeks (about 4 to 5 months) after your last injection before the drug is essentially gone from your blood. This is longer than many conventional medications because Nucala is a monoclonal antibody, a large protein that your body breaks down slowly through natural protein recycling rather than processing it through your liver or kidneys like a typical pill.
Why Steady-State Matters
If you’ve been on Nucala for several months, the drug has accumulated in your system beyond what a single dose would produce. Because injections are given every 4 weeks and the half-life is about the same length, each new dose arrives before the previous one has fully cleared. According to FDA prescribing data, this creates roughly a 2-fold accumulation at steady state, meaning the drug concentration in your blood at the time of your last dose is about double what it would be after a single injection.
That higher starting concentration doesn’t dramatically change the total clearance window, but it does mean the drug lingers at meaningful levels for a bit longer than the simple 5-half-life calculation would suggest for a one-time dose. In practical terms, you’re still looking at roughly 4 to 5 months before Nucala is functionally eliminated, but drug levels stay higher for more of that period compared to someone who only received one injection.
How Long the Effects Last After Stopping
The drug leaving your bloodstream is one thing. Your body returning to its pre-treatment state is another. Nucala works by blocking a specific signaling protein that drives eosinophil production (a type of white blood cell involved in inflammation). Once the drug clears, those signals start firing again, but the rebound isn’t instant.
A 12-month follow-up study published in the Journal of Allergy and Clinical Immunology tracked what happened after people with severe eosinophilic asthma stopped mepolizumab. Blood eosinophil counts began climbing within the first 3 months after the last dose and continued rising between months 3 and 6. By about 6 months, eosinophil levels had returned to their pre-treatment baseline. This means even after the drug itself has cleared, you may still see some residual suppression of eosinophils for a few weeks before they fully recover.
For symptoms, this translates to a gradual return rather than a sudden worsening. Most people don’t notice an immediate flare the day after a missed dose or after stopping treatment. The protective effect fades over weeks to months as eosinophil-driven inflammation rebuilds.
Factors That Can Affect Clearance Time
Because Nucala is a large protein broken down by your body’s normal protein-degrading processes rather than by your liver or kidneys, kidney disease and liver disease don’t appear to significantly change how long it stays in your system. This is different from many conventional drugs where organ function plays a major role in clearance speed.
Body weight does matter. Nucala’s clearance rate is estimated at 0.28 liters per day for a 70-kilogram (154-pound) adult with asthma. Heavier individuals generally clear antibody-based drugs somewhat faster, while lighter individuals may clear them more slowly, though the clinical difference is usually modest.
Age also plays a role at the younger end of the spectrum. In adolescents studied during clinical trials, clearance was about 35% slower than in adults, meaning the drug stays in a teenager’s system somewhat longer. For adult age ranges, no clinically meaningful differences have been identified.
Practical Timeline Summary
- Drug half-life: 3 to 4 weeks per half-life cycle
- Near-complete elimination: approximately 4 to 5 months after the last injection
- Eosinophil recovery: gradual rise over 3 to 6 months, returning to baseline around month 6
- Symptom return: varies by individual, but typically begins within weeks to a few months after stopping
If you’re stopping Nucala for a specific reason, such as switching treatments, planning a medical procedure, or managing side effects, the key number to keep in mind is that 6-month window. That’s roughly how long it takes for both the drug to clear and your eosinophil levels to fully reset. During that transition period, your body is gradually shifting back toward its untreated baseline.